Revance Therapeutics, Inc.
SEC CIK 1479290 · RVNC · last insider filing 2025-02-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Beraud Jill | Director | filed 2019 - 2025 |
| Foley Mark J | Director · President & CEO | filed 2017 - 2025 |
| Gangolli Julian S | Director | filed 2016 - 2025 |
| Russell Angus C. | Director | filed 2014 - 2025 |
| Ware Olivia C | Director | filed 2021 - 2025 |
| Coric Vlad | Director | filed 2023 - 2025 |
| Nolet Chris | Director | filed 2019 - 2025 |
| Kolaja Carey Oconnor | Director | filed 2021 - 2025 |
| Vickers Philip J. | Director | filed 2015 - 2022 |
| Rankin Aubrey | Director · President, Innovation & Tech | filed 2020 - 2022 |
| Gardner Phyllis | Director | filed 2014 - 2020 |
| Byrnes Robert F | Director | filed 2014 - 2020 |
| Browne L Daniel | Director · CEO and President | filed 2014 - 2019 |
| Eastman Ronald W | Director | filed 2014 - 2017 |
| Prygocki Mark A SR | Director | filed 2014 - 2016 |
| Glasheen James Walter | Director | filed 2014 - 2016 |
| Wooten Ronald J | Director | filed 2014 - 2015 |
| Tunnicliffe Jonathan | Director | filed 2014 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Schilke Tobin | Chief Financial Officer | filed 2018 - 2025 |
| Hollander David | CMO & Global Therapeutics Lead | filed 2024 - 2025 |
| Moxie Dwight | SVP, GC & Secretary | filed 2020 - 2025 |
| Jordan Erica | Chief Commercial Officer | filed 2024 - 2025 |
| Sjuts Dustin S | President | filed 2019 - 2024 |
| Joshi Abhay | Chief Operating Officer | filed 2015 - 2022 |
| Mcdowell Caryn Gordon | SVP, GC & Secretary | filed 2018 - 2020 |
| Allouche Cyril | Principal Financial Officer | filed 2018 - 2019 |
| Zavodnick Todd Erik | Chief Commercial Officer | filed 2017 - 2018 |
| Silvernail Lauren P | CFO, Seretary & EVP Corp Dev. | filed 2014 - 2018 |
| Ruegg Curtis | EVP, Technical Operations | filed 2014 - 2016 |
| Bertolino Arthur Peter | EVP and Chief Medical Officer | filed 2014 - 2015 |
| Waugh Jacob | Chief Scientific Officer | filed 2014 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.